Maternal-fetal immunologic response to SARS-CoV-2 infection in a symptomatic vulnerable population: A prospective cohort.
Ramon LarcadeLise DeSheaGillian A LangMauricio T CaballeroAdrian FerrettiWilliam H BeasleyTrent E TippleNestor VainLuis PrudentMark L LangFernando PolackGaston Ofmannull nullPublished in: The Journal of infectious diseases (2021)
These results demonstrate the combined role of biologic, clinical and socioeconomic variables associated with maternal SARS-CoV-2 RBD-specific antibodies and supports early vaccination strategies for COVID-19 in socioeconomically vulnerable pregnant women.